Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Clinical Neuropharmacology|December 17, 2004
Effectiveness of milnacipran for the treatment of chronic pain: a case seriesMitsuhiro Kamata, Hitoshi Takahashi, Shingo Naito, et al.
Neuropsychiatric Disease and Treatment|August 4, 2009
Influence of serotonergic/noradrenergic gene polymorphisms on nausea and sweating induced by milnacipran in the treatment of depressionHisashi Higuchi, Hitoshi Takahashi, Mitsuhiro Kamata, et al.
Clinical Neuropharmacology|August 3, 2005
Remarkable effect of selegiline (L-deprenyl), a selective monoamine oxidase type-B inhibitor, in a patient with severe refractory depression: a case reportHisashi Higuchi, Mitsuhiro Kamata, Yuka Sugawara, et al.
International Journal of Psychiatry in Clinical Practice|June 12, 2014
Efficacy of milnacipran in the treatment of chronic pain syndromesMitsuhiro Kamata, Shingo Naito, Hisashi Higuchi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 8, 2005
Remarkable effect of milnacipran, a serotonin-noradrenalin reuptake inhibitor (SNRI), on depressive symptoms in patients with Parkinson's disease who have insufficient response to selective serotonin reuptake inhibitors (SSRIs): two case reportsHitoshi Takahashi, Mitsuhiro Kamata, Keizo Yoshida, et al.
The Journal of Clinical Psychiatry|November 17, 2006
Switching to olanzapine after unsuccessful treatment with risperidone during the first episode of schizophrenia: an open-label trialHitoshi Takahashi, Mitsuhiro Kamata, Keizo Yoshida, et al.
Human Psychopharmacology|January 4, 2008
Augmentation with olanzapine in TCA-refractory depression with melancholic features: a consecutive case seriesHitoshi Takahashi, Mitsuhiro Kamata, Keizo Yoshida, et al.
Journal of Affective Disorders|September 16, 2011
Genetic polymorphisms in the serotonergic system and symptom clusters of major depressive disorderMitsuhiro Kamata, Akihito Suzuki, Keizo Yoshida, et al.
Neuropsychiatric Disease and Treatment|June 28, 2017
Association between serotonin transporter polymorphisms (5-HTTLPR) and the MADRS Dysphoria, Retardation, and Vegetative Subscale scores in the treatment of depressionHitoshi Takahashi, Hisashi Higuchi, Kazuhiro Sato, et al.
Neuropsychiatric Disease and Treatment|June 27, 2009
Differential clinical effects of fluvoxamine by the effect of age in Japanese female major depressive patientsHisashi Higuchi, Kazuhiro Sato, Shingo Naito, et al.
Pageof 7